Dimensional Fund Advisors
AEGR

Dimensional Fund Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History

Dimensional Fund Advisors’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-930
Closed -$43K – 3602
2014
Q1 		$43K Sell
930
-213
-19% -$12.5K ﹤0.01% 3463
2013
Q4 		$81K Sell
1,143
-65,122
-98% -$4.98M ﹤0.01% 3372
2013
Q3 		$5.68M Buy
+66,265
New +$5.62M ﹤0.01% 2477

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors's AEGR Position: Q2 2014 in Review

Dimensional Fund Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2014, closing a stake of 930 shares — an estimated $43K sold.

Dimensional Fund Advisors first reported a position in AEGR in Q3 2013 and held it in 3 quarters. The position peaked at $5.68M in Q3 2013. 129 funds tracked by Wall St. Rank hold AEGR as of Q2 2014.

  • Dimensional Fund Advisors reported no remaining Aegerion Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Dimensional Fund Advisors sold 930 Aegerion Pharmaceuticals shares in Q2 2014, an estimated $43K.
  • Dimensional Fund Advisors first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • Dimensional Fund Advisors's Aegerion Pharmaceuticals position peaked at $5.68M in Q3 2013.
  • 129 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2014.

Based on Dimensional Fund Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.